As HR professionals contemplate workplace decisions to manage employer risk, various questions about cannabis, marijuana, hemp, and cannabinoids may arise. But accurate and objective information about the benefits and risks of cannabis, marijuana, cannabidiol (CBD), hemp, and other cannabinoids can be hard to find.

In this free, one-hour presentation, an attorney who practices drug law and policy, a PhD behavioral health psychologist, and the chief operating officer of a substance use disorder prevention and harm reduction organization, will share well-documented, up-to-date information on cannabinoid products. Their objective is to help equip participants to make informed risk management decisions.

The speakers will examine definitions and the U.S. federal and state legal status of cannabis, marijuana, hemp, CBD, and other cannabinoid products. They will discuss products' research and evidence base and Food and Drug Administration (FDA) approval status, which is essential to understanding the health and safety profiles of these products.

This webinar will cover cannabinoid-related topics of specific interest to employers and HR professionals, such as health insurance coverage, employee assistance programs, workplace safety, and recovery support. The speakers will discuss anticipated cannabinoid-related developments that could affect employer risk management. They will also direct participants to credible resources to support their ongoing decision-making. Finally, the session will conclude with a live Q&A session.